Your session is about to expire
← Back to Search
Geriatric Assessment for Cancer Survivorship
Study Summary
This trial will test whether giving an older cancer survivor a care plan and follow-up visit improves their quality of life.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 65 years old or older.I have cancer and finished chemotherapy aimed at curing it.I am scheduled to get a care plan from a cancer care specialist.I live in a nursing home.I do not have advanced dementia or serious cognitive issues that would prevent me from participating in an interview.
- Group 1: No intervention arm
- Group 2: Active comparator arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total number of participants enrolled in this investigation?
"Affirmative. According to clinicaltrials.gov, this scientific trial is actively recruiting participants; it was initially posted on February 16th 2021 and underwent its most recent update on March 22nd 2022. The research requires 70 individuals from 1 medical facility."
What are the chief aims of this trial?
"This medical study is expected to take between 4-6 months, with the primary outcome being completion rates. Secondary objectives include evaluating patient health and quality of life through QLQ-ELD14 that assesses mobility, worries about others, future worries, maintaining purpose and burden of illness alongside two single items (joint stiffness and family support). Additionally, self rated knowledge will be evaluated using PLANS assessment tool which measures survivor satisfaction along a four point scale. Lastly, Patient Satisfaction with Cancer related Care tool (PSCC) will measure participant's level of agreement on five point Likert scales in order to gauge their overall satisfaction."
Are investigators still enrolling participants in this research?
"Reports from clinicaltrials.gov confirm that this medical trial is currently recruiting patients, with the initial listing posted on February 16th 2021 and last updated on March 22nd 2022."
Share this study with friends
Copy Link
Messenger